No Data
No Data
Nishimatsu Construction, Asahi Group Holdings, etc. (Part 1)
<1820> Nishimatsu Construction Co., Ltd. Itochu Corporation shareholding ratio 12.43% → 13.53% Reporting obligation date 2024/08/29<2134> Kitahama Capital Partners Co., Ltd. SUN ORGANIC FARM Co., Ltd. shareholding ratio 73.75% → 71.41% Reporting obligation date 2024/08/14<2502> Asahi Group Holdings, Ltd. Mitsui Sumitomo Trust Asset Management
List of conversion stocks (Part 3) [List of parabolic signal conversion stocks]
○ Sell conversion stock list market Code Stock Name Close SAR Tokyo Main Board <4538> Fusso Pharmaceutical 2188 2298<4543> Terumo 2645 2810<4559> Zeria Pharmaceutical 2251 2324<4633> Sakata Inx 1577 1704<4674> Cresco
Sumitomo Mitsui Trust Asset Management holds 5.09% of shares in Dexerials(4980.JP)
On Sep 5, Sumitomo Mitsui Trust Asset Management and related parties submitted the Large Shareholding Report to Ministry of Finance to disclose its 5.09% ownership of the shares in $Dexerials(4980.JP)
Dexerials Corp Honored in JPX-Nikkei Index 400 Again
August 23rd [Today's Investment Strategy]
[Fisco Selected Stocks] [Material Stocks] Oriental Consultants Holdings <2498> 3405 yen (8/22) construction consultant. The company announced that the year-end dividend (= annual dividend) forecast for the fiscal year ending September 2024 is 175 yen. The previous forecast was 100 yen, and the previous period was also 100 yen. The company recognizes the long-term stable profit return to shareholders as one of the important management challenges, and also takes into account the trends in past consolidated performance, the outlook for future consolidated performance, dividend payout ratio and dividend yield.
Pay attention to Okuma and Eisai [Today's individual stock trends]
On November 22, the NYダウ fell 177.71 points to 40,712.78, and the NASDAQ composite index fell 299.63 points to 17,619.36. In the Chicago Nikkei 225 futures, it fell 180 yen to 38,050 yen compared to Osaka during the day. The exchange rate is 1 dollar = 146.20-30 yen. In today's Tokyo market, Okuma <6103> announced a stock split of 2 shares per share, Eisai <4523> announced that Lecanemab has obtained approval as an early Alzheimer's disease treatment drug in the UK.
No Data
No Data